Health officials are reminding the public that antibiotics are ineffective against respiratory infections caused by viruses, ...
FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...
Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.
The findings come on the cusp of the Northern Hemisphere flu and respiratory syncytial virus seasons and rising US COVID-19 ...